You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2025

Details for Patent: 4,725,439


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,725,439
Title: Transdermal drug delivery device
Abstract:A medical device for the transdermal delivery of an active agent through sensitive intact skin is provided. The device comprises a matrix containing the drug having reinforcing means, preferably in the form of a fabric, embedded in the upper surface of the matrix. The matrix is formed of an agent permeable material which is tacky but does not adhesively bond to the skin. The device is sufficiently flexible and deformable that the combination of tackiness, flexibility, and deformation permits the device to be maintained in agent transmitting relationship upon skin at such sensitive areas as the scrotum, labia, breast, or penis, for example. In certain embodiments, the skin distal surface is provided with a layer of an agent impermeable material to reduce transfer of the agent from the patient to others.
Inventor(s): Campbell; Patricia S. (Palo Alto, CA), Eckenhoff; James B. (Los Altos, CA), Place; Virgil A. (Kawaihae, HI)
Assignee: ALZA Corporation (Palo Alto, CA)
Application Number:06/818,561
Patent Claim Types:
see list of patent claims
Device; Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,725,439: A Detailed Analysis

Introduction

Patent analysis is a crucial aspect of intellectual property law, particularly when it comes to understanding the scope and claims of a patent. This article will delve into the specifics of United States Patent 4,725,439, examining its claims, the patent landscape, and relevant legal and technical aspects.

Background of the Patent

United States Patent 4,725,439, though not explicitly detailed in the provided sources, typically involves a specific invention or innovation. To analyze this patent, one must refer to the patent document itself, which includes the background of the invention, the summary of the invention, and the detailed description.

Claims of the Patent

Definition and Requirements

The claims of a patent are the most critical part of the patent document as they define the matter for which protection is sought. According to the USPTO guidelines, claims must be clear, concise, and fully supported by the description provided in the patent[5].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Claim Analysis

For a detailed analysis, one would need to review the specific claims of the patent. Here are some general steps:

  • Identify Independent Claims: Determine the core aspects of the invention.
  • Analyze Dependent Claims: Understand how these claims further define and limit the invention.
  • Check for Support: Ensure that each claim is fully supported by the description provided in the patent.

Patent Scope and Breadth

Metrics for Measuring Patent Scope

Research has shown that patent scope can be measured using metrics such as independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Impact on Patent Quality

The breadth and clarity of patent claims are crucial in debates over patent quality. Overly broad claims can lead to increased licensing and litigation costs, potentially diminishing incentives for innovation. A detailed analysis of the claims in US Patent 4,725,439 would help in understanding whether the patent aligns with these metrics.

Patent Landscape

Historical Context

Understanding the historical context in which the patent was filed and granted is essential. This includes looking at prior art and other patents in the same field. The Patent Claims Research Dataset provided by the USPTO can be a valuable resource for this analysis, offering detailed information on claims from US patents granted between 1976 and 2014[2].

Related Patents and Prior Art

Identifying related patents and prior art helps in understanding the novelty and non-obviousness of the invention. For example, if there are similar patents with overlapping subject matter, it could raise questions about the uniqueness of the invention claimed in US Patent 4,725,439.

Legal Considerations: Double Patenting

Obviousness-Type Double Patenting (ODP)

The doctrine of obviousness-type double patenting (ODP) is designed to prevent an inventor from securing a second, later-expiring patent for the same invention. This is particularly relevant if the patent in question has different expiration dates due to patent term adjustments (PTA) or patent term extensions (PTE)[1].

Impact on Patent Term

The Federal Circuit has addressed the interplay between ODP and PTA/PTE in several decisions. For instance, the Ezra decision clarified that the judicially created ODP doctrine cannot cut off a statutorily authorized patent term extension[1].

Technical Aspects

Invention Details

The technical details of the invention, as described in the patent document, are crucial for understanding its scope and claims. This includes the background of the invention, the summary of the invention, and the detailed description.

Comparison with Similar Inventions

Comparing the invention with similar ones in the field can help in identifying its unique features and contributions. This comparison can also highlight any potential issues with the patent's validity or enforceability.

Industry Impact and Innovation

Licensing and Litigation

The scope and claims of a patent can significantly impact licensing and litigation strategies. Overly broad or unclear claims can lead to disputes and increased costs, while well-defined claims can facilitate smoother licensing agreements and reduce litigation risks.

Innovation Incentives

The clarity and breadth of patent claims can influence innovation incentives. Patents that are too broad may stifle innovation by creating barriers to entry for other inventors, while patents with clear and reasonable claims can encourage further innovation in the field.

Key Takeaways

  • Clear and Concise Claims: Ensure that the claims are clear, concise, and fully supported by the description.
  • Patent Scope Metrics: Use metrics like independent claim length and count to assess the breadth and clarity of the patent.
  • Legal Considerations: Be aware of the doctrine of obviousness-type double patenting and its implications on patent term.
  • Technical Details: Understand the technical aspects of the invention and compare them with similar inventions.
  • Industry Impact: Recognize the impact of patent claims on licensing, litigation, and innovation incentives.

FAQs

What are the key components of a patent claim?

The key components include being clear, concise, and fully supported by the description provided in the patent.

How is patent scope measured?

Patent scope can be measured using metrics such as independent claim length and independent claim count.

What is obviousness-type double patenting (ODP)?

ODP is a doctrine designed to prevent an inventor from securing a second, later-expiring patent for the same invention.

How does the Ezra decision impact patent term extensions?

The Ezra decision clarified that the judicially created ODP doctrine cannot cut off a statutorily authorized patent term extension.

Why is the clarity of patent claims important?

Clear and reasonable claims can facilitate smoother licensing agreements, reduce litigation risks, and encourage further innovation in the field.

Sources

  1. US Update: Double Patenting - Finnegan
  2. Patent Claims Research Dataset - USPTO
  3. Patent Claims and Patent Scope - SSRN
  4. United States Patent 5,741,510 - Google Patents
  5. The Claims - USPTO MPEP

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,725,439

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 4,725,439

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Canada 1257819 ⤷  Try for Free
Germany 3523065 ⤷  Try for Free
Germany 3687067 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.